发明授权
- 专利标题: Morpholine type cinnamide compound
- 专利标题(中): 吗啉型肉桂酰胺化合物
-
申请号: US11594130申请日: 2006-11-08
-
公开(公告)号: US07618960B2公开(公告)日: 2009-11-17
- 发明人: Teiji Kimura , Koki Kawano , Eriko Doi , Noritaka Kitazawa , Mamoru Takaishi , Koichi Ito , Toshihiko Kaneko , Takeo Sasaki , Nobuaki Sato , Takehiko Miyagawa , Hiroaki Hagiwara
- 申请人: Teiji Kimura , Koki Kawano , Eriko Doi , Noritaka Kitazawa , Mamoru Takaishi , Koichi Ito , Toshihiko Kaneko , Takeo Sasaki , Nobuaki Sato , Takehiko Miyagawa , Hiroaki Hagiwara
- 申请人地址: JP Tokyo
- 专利权人: Eisai R&D Management Co., Ltd.
- 当前专利权人: Eisai R&D Management Co., Ltd.
- 当前专利权人地址: JP Tokyo
- 代理机构: Birch, Stewart, Kolasch & Birch, LLP
- 优先权: JP2005-337952 20051124; JP2006-205591 20060728
- 主分类号: C07D498/04
- IPC分类号: C07D498/04 ; A61K31/5375
摘要:
The present invention relates to a compound represented by the formula (I): or a pharmacologically acceptable salt thereof, wherein R1, R2, R3, and R4 are the same or different and each represent a hydrogen atom or a C1-6 alkyl group; X1 represents a C1-6 alkylene group that may be substituted; Xa represents a methoxy group or a fluorine atom; Xb represents an oxygen atom or a methylene group, provided that Xb is only an oxygen atom when Xa is a methoxy group; and Ar1 represents an aryl group, pyridinyl group, aryloxy group, or pyridinyloxy group that may have a substituent such as a halogen atom; and to use of the compound or salt as a pharmaceutical agent.
公开/授权文献
- US20070117798A1 Morpholine type cinnamide compound 公开/授权日:2007-05-24
信息查询